We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Avandia Survives Scrutiny From FDA Panel

Law360 (July 31, 2007, 12:00 AM EDT) -- After a contentious day of hearings, a panel of U.S. Food and Drug Administration advisers has overwhelmingly voted to keep Avandia on the market despite data that suggests the controversial diabetes...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.